-
Forward Look
Pediatric Leukemia Treatments Are Not Just for KidsStudy supports using these regimens for teens and young adults.
by Bradley Jones
-
Forward Look
Learning How to Prevent Multiple MyelomaIrene Ghobrial on studying cancer precursors.
by Sue Rochman
-
Coping With TraumaNearly six years after being diagnosed with stage IV colon cancer, disaster psychologist Jamie Aten is still learning new ways of coping with the trauma stemming from his diagnosis and treatment.
by Jamie Aten
-
Lung Cancer and StigmaClinical health psychologist Jamie Ostroff discusses how feelings of blame surrounding a lung cancer diagnosis affect physical and mental health.
by Jen Tota McGivney
-
New Rule Would Require Breast Density DisclosureA proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
-
PARP Inhibitors in Pancreatic CancerDrugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.
by Kate Yandell
-
What Not to Say to a Cancer PatientWhen visiting a friend or family member who is sick, it's good to leave platitudes at the door.
by Michael Gavaghen
-
Healthy Habits
Fiber’s BenefitsEating more roughage may yield benefits following a colorectal cancer diagnosis.
by Lindsey Konkel
-
Forward Look
Looking for Brain MetastasesStudies aim to identify when screening is beneficial.
by Sue Rochman
-
Forward Look
For Cancer Researchers, Dogs Offer Clues to Help KidsSimilarities between cancers create path for studying new treatments.
by Cameron Walker
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
